Rosen Law Firm’s probe into Tandem Diabetes Care (TNDM) after a voluntary correction of certain t:slim X2 insulin pumps, and the roughly 20% share drop that followed, has investors reassessing risk ...
Abstract: This paper describes personalised, intelligent methods for designing an automated artificial pancreas (AP) to regulate type 1 diabetes blood sugar. Initial insulin-glucose regulation can be ...
[Image from Renu MedTech on LinkedIn] Renu MedTech today unveiled InsuPatch, its tubeless insulin patch pump designed specifically for advancing diabetes care in India. On LinkedIn, the Pune, ...
The US Food and Drug Administration (FDA) has granted clearance for the Android version of Tandem Diabetes Care’s Tandem Mobi ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration (FDA) has ...